Evidence map›Paper›PMID 33583891›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Cholinergic Crisis Owing to Distigmine Bromide Complicated by Hyperosmolar Hyperglycemic State.

Kazumasa Kotake, Atsuhito Tone, Satoko Watanabe, Mayumi Senoo, Mitsuhiro Kaneto, Yusuke Imai, Sanae Teshigawara, Yasuhiro Kawakami, Tatsuaki Nakatou

Abstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kazumasa KotakeDepartment of Pharmacy, Okayama Saiseikai General Hospital, Japan.
Atsuhito ToneDepartment of Internal Medicine, Diabetes Center, Okayama Saiseikai General Hospital, Japan.
Satoko WatanabeDepartment of Internal Medicine, Diabetes Center, Okayama Saiseikai General Hospital, Japan.
Mayumi SenooDepartment of Internal Medicine, Diabetes Center, Okayama Saiseikai General Hospital, Japan.
Mitsuhiro KanetoDepartment of Internal Medicine, Diabetes Center, Okayama Saiseikai General Hospital, Japan.
Yusuke ImaiDepartment of Internal Medicine, Diabetes Center, Okayama Saiseikai General Hospital, Japan.
Sanae TeshigawaraDepartment of Internal Medicine, Diabetes Center, Okayama Saiseikai General Hospital, Japan.
Yasuhiro KawakamiDepartment of Pharmacy, Okayama Saiseikai General Hospital, Japan.
Tatsuaki NakatouDepartment of Internal Medicine, Diabetes Center, Okayama Saiseikai General Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Distigmine bromide is widely used to treat neurogenic bladder and causes cholinergic crisis, a serious side effect. We herein report about a patient with distigmine bromide-induced cholinergic crisis complicated by a hyperosmolar hyperglycemic state (HHS). On admission, the patient was diagnosed with HHS based on the medical history and laboratory test results. However, she also had bradycardia, miosis, and low plasma cholinesterase activity. We later found that she had received distigmine bromide, which led to a diagnosis of cholinergic crisis. We suggest that the exacerbation of pathology, including HHS, can cause cholinergic crisis in patients receiving distigmine bromide.

Indexed as

Hyperglycemic Hyperosmolar Nonketotic ComaBradycardiaCholinesterase InhibitorsFemaleHumansPyridinium CompoundsCholinesterase InhibitorsdistigminePyridinium Compoundsbradycardiacholinergic crisisdistigmine bromidehyperosmolar hyperglycemic statelow plasma cholinesterase activitymiosis

Identifiers

PMID33583891
PMCPMC8355397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.